ArticleBiological trace element research2026
Cadmium-Induced Structural Destabilization of the Insulin-Zinc Complex Underlies the Paradox of Elevated but Dysfunctional Insulin.
Article in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Chronic cadmium (Cd) exposure, even in environmental conditions, has been associated with metabolic disorders such as dyslipidemia, insulin resistance, and type 2 diabetes. However, the molecular mechanisms underlying Cd-induced endocrine-metabolic disruption remain unclear. Using a multidisciplinary approach that combines in vivo, in vitro, and in silico analyses, we examined the effects of environmentally relevant Cd concentrations on lipids and glucose homeostasis, β-cell proliferation, insulin secretion, and the biofunctionality of insulin-Cd complex. Male Wistar rats were exposed orally to CdCl₂ (15 or 32 ppm) for three months. zoometric, glycemic, and lipid parameters were evaluated, along with markers of glucose-stimulated insulin secretion (GSIS), β-cell proliferation (Ki-67), and survival (Bcl-2). Crystallographic, spectroscopic (UV-Vis, FTIR), and in silico analyses characterized the coordination chemistry of Zn²⁺ and Cd²⁺ within insulin complexes, and the biological activity of insulin-Cd was assessed in diabetic models. Cd exposure produced a dose-dependent increase in zoometric and biochemical parameters, accompanied by hyperinsulinemia and impaired β-cell function. Isolated islets showed exaggerated second-phase insulin release and increased Ki-67 with reduced Bcl-2 immunoreactivity, suggesting compensatory β-cell proliferation under subtoxic stress. Spectroscopic and theoretical analyses support the possibility that Cd²⁺ substitutes Zn²⁺ within insulin coordination sites, leading to structural perturbations. In vivo, insulin-Cd conjugates exhibited diminished hypoglycemic efficacy despite elevated circulating insulin levels, indicating reduced bioactivity. In conclusion, Cd exposure at the experimental concentrations used in this study is associated with structural perturbations of insulin and markedly reduced biological activity, providing a plausible mechanism for Cd-induced metabolic dysfunction.
Indexed as
Identifiers
42521927What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.